| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |